Chemours (CC) Non-Current Deffered Revenue (2015 - 2021)

Chemours' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $2.0 million for Q4 2021.

• In Q4 2021, Non-Current Deffered Revenue fell 60.0% year-over-year to $2.0 million; the TTM figure through Dec 2021 stood at $2.0 million (down 60.0% YoY), while the FY2021 annual figure was $2.0 million, down 60.0% from the prior year.
• Non-Current Deffered Revenue was $2.0 million for Q4 2021 at Chemours, down from $5.0 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $8.0 million in Q3 2018 to a low of $2.0 million in Q4 2021.
• Historically, Non-Current Deffered Revenue has averaged $5.5 million across 5 years, with a median of $5.0 million in 2018.
• The sharpest annual moves came in 2017 and 2021: Non-Current Deffered Revenue advanced 20.0% in 2017, then sank 60.0% in 2021.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $6.0 million in 2017, then gained by 16.67% to $7.0 million in 2018, then rose by 14.29% to $8.0 million in 2019, then sank by 37.5% to $5.0 million in 2020, then tumbled by 60.0% to $2.0 million in 2021.
• The last three Non-Current Deffered Revenue figures came in at $2.0 million (Q4 2021), $5.0 million (Q3 2021), and $5.0 million (Q2 2021), per Business Quant data.